Back
Novartis AG Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
47
NVS
Novartis AG
Last Price:
$99.10
Seasonality Move:
-1.76%
Sell
42
ITCI
Intra-Cellular Therapies
Last Price:
$94.86
Seasonality Move:
2.9%
Sell
47
Novartis AG (NVS)
is a Sell
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVS] share price is $99.08. The Score for NVS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
NVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
-
The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $99.08The current trend is relatively stagnant and NVS is experiencing selling pressure, which indicates risk of future bearish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $94.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.
NVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.08 | Sell |
| Relative Strength Index (14 RSI): | 46.3 | Sell |
| Chaikin Money Flow: | -1181922 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (97.18 - 100.48) | Buy |
| Bollinger Bands (100): | (101.63 - 116.95) | Sell |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.52 | Buy |
| Relative Strength Index (14 RSI): | 71.02 | Buy |
| Chaikin Money Flow: | 1717350 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.26 - 87.1) | Buy |
| Bollinger Bands (100): | (74.04 - 85.96) | Buy |
NVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 98.18 | Buy |
| 20-day SMA: | 98.13 | Buy |
| 50-day SMA: | 102.3 | Sell |
| 200-day SMA: | 106.34 | Sell |
| 8-day EMA: | 98.62 | Buy |
| 20-day EMA: | 99.05 | Buy |
| 50-day EMA: | 102.34 | Sell |
| 200-day EMA: | 105.61 | Sell |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.68 | Buy |
| 20-day SMA: | 84.71 | Buy |
| 50-day SMA: | 85.48 | Buy |
| 200-day SMA: | 75.72 | Buy |
| 8-day EMA: | 85.91 | Buy |
| 20-day EMA: | 85.03 | Buy |
| 50-day EMA: | 83.75 | Buy |
| 200-day EMA: | 76.64 | Buy |
Novartis AG Earnings Growth & NVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.47 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.
Novartis AG Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||